| ANAB |
ANAPTYSBIO, INC |
06 Jan 2026 |
2 |
$0 |
4 |
Director |
08 Jan 2026, 16:04 |
| ANAB |
ANAPTYSBIO, INC |
23 Dec 2025 |
1 |
-$564,468 |
4 |
Director |
23 Dec 2025, 16:29 |
| BBOT |
BridgeBio Oncology Therapeutics, Inc. |
11 Aug 2025 |
2 |
$0 |
4 |
Former Director |
11 Aug 2025, 17:00 |
| ANAB |
ANAPTYSBIO, INC |
15 Jun 2025 |
2 |
$0 |
4 |
Director |
17 Jun 2025, 18:30 |
| DSGN |
Design Therapeutics, Inc. |
10 Jun 2025 |
1 |
$0 |
4 |
Director |
12 Jun 2025, 16:30 |
| ANAB |
ANAPTYSBIO, INC |
25 Mar 2025 |
1 |
+$201,241 |
4 |
Director |
27 Mar 2025, 16:10 |
| ANAB |
ANAPTYSBIO, INC |
13 Jan 2025 |
4 |
+$275,007 |
4 |
Director |
15 Jan 2025, 17:04 |
| PSTX |
Poseida Therapeutics, Inc. |
08 Jan 2025 |
9 |
$0 |
4 |
Director |
08 Jan 2025, 14:16 |
| ANAB |
ANAPTYSBIO, INC |
07 Jan 2025 |
2 |
$0 |
4 |
Director |
07 Jan 2025, 17:28 |
| XERS |
Xeris Biopharma Holdings, Inc. |
12 Aug 2024 |
1 |
+$10,147 |
4 |
Director |
13 Aug 2024, 16:15 |
| XERS |
Xeris Biopharma Holdings, Inc. |
09 Aug 2024 |
1 |
+$10,134 |
4 |
Director |
12 Aug 2024, 18:28 |
| PSTX |
Poseida Therapeutics, Inc. |
17 Jun 2024 |
2 |
$0 |
4 |
Director |
18 Jun 2024, 16:16 |
| ANAB |
ANAPTYSBIO, INC |
15 Jun 2024 |
2 |
$0 |
4 |
Director |
18 Jun 2024, 20:17 |
| DSGN |
Design Therapeutics, Inc. |
13 Jun 2024 |
1 |
$0 |
4 |
Director |
17 Jun 2024, 17:00 |
| XERS |
Xeris Biopharma Holdings, Inc. |
05 Jun 2024 |
1 |
$0 |
4 |
Director |
05 Jun 2024, 16:19 |
| XERS |
Xeris Biopharma Holdings, Inc. |
10 May 2024 |
1 |
+$10,314 |
4 |
Director |
10 May 2024, 16:04 |
| DSGN |
Design Therapeutics, Inc. |
22 Mar 2024 |
2 |
+$99,738 |
4 |
Director |
25 Mar 2024, 19:10 |
| XERS |
Xeris Biopharma Holdings, Inc. |
14 Mar 2024 |
1 |
+$9,720 |
4 |
Director |
14 Mar 2024, 21:03 |
| HLXB |
Helix Acquisition Corp. II |
08 Feb 2024 |
0 |
$0 |
3 |
Director |
09 Feb 2024, 06:13 |
| ANAB |
ANAPTYSBIO, INC |
03 Jan 2024 |
2 |
$0 |
4 |
Director |
05 Jan 2024, 16:58 |
| XERS |
Xeris Biopharma Holdings, Inc. |
16 Nov 2023 |
1 |
+$9,815 |
4 |
Director |
17 Nov 2023, 18:35 |
| PSTX |
Poseida Therapeutics, Inc. |
15 Jun 2023 |
2 |
$0 |
4 |
Director |
16 Jun 2023, 16:09 |
| XERS |
Xeris Biopharma Holdings, Inc. |
07 Jun 2023 |
1 |
$0 |
4 |
Director |
07 Jun 2023, 16:55 |
| DSGN |
Design Therapeutics, Inc. |
31 May 2023 |
1 |
$0 |
4 |
Director |
02 Jun 2023, 16:31 |
| ANAB |
ANAPTYSBIO, INC |
06 Jan 2023 |
2 |
$0 |
4 |
Director |
10 Jan 2023, 18:11 |
| PSTX |
Poseida Therapeutics, Inc. |
16 Jun 2022 |
2 |
$0 |
4 |
Director |
16 Jun 2022, 20:56 |
| DSGN |
Design Therapeutics, Inc. |
15 Jun 2022 |
1 |
$0 |
4 |
Director |
16 Jun 2022, 17:10 |
| XERS |
Xeris Biopharma Holdings, Inc. |
08 Jun 2022 |
2 |
$0 |
4 |
Director |
09 Jun 2022, 17:13 |
| ANAB |
ANAPTYSBIO, INC |
10 Feb 2022 |
1 |
$0 |
4 |
Director |
14 Feb 2022, 15:50 |
| XERS |
Xeris Biopharma Holdings, Inc. |
05 Oct 2021 |
5 |
$0 |
4 |
Director |
05 Oct 2021, 19:41 |
| XERS |
XERIS PHARMACEUTICALS INC |
05 Oct 2021 |
5 |
$0 |
4 |
Director |
05 Oct 2021, 17:37 |
| XERS |
Xeris Biopharma Holdings, Inc. |
05 Oct 2021 |
0 |
$0 |
3 |
Director |
05 Oct 2021, 17:23 |
| PSTX |
Poseida Therapeutics, Inc. |
23 Jul 2021 |
1 |
$0 |
4 |
Director |
26 Jul 2021, 20:32 |
| PSTX |
Poseida Therapeutics, Inc. |
16 Jun 2021 |
1 |
$0 |
4 |
Director |
17 Jun 2021, 17:03 |
| XERS |
XERIS PHARMACEUTICALS INC |
08 Jun 2021 |
1 |
$0 |
4 |
Director |
08 Jun 2021, 19:08 |